CannapharmaRX Secures Multi-Year Supply Deal with Cantek
Company Announcements

CannapharmaRX Secures Multi-Year Supply Deal with Cantek

Cannapharmarx Inc (CPMD) has released an update.

CannaPharmaRX, Inc. has entered into a three-year Supply Agreement with Israeli corporation D.N.S. Cantek 2019 Ltd., stipulating that Cantek will buy a minimum of 1,000 kg of the company’s products annually at $2.75 CDN per gram. The deal includes a most-favored nation clause ensuring Cantek receives the best pricing available and standard termination clauses. Shareholders and interested parties are encouraged to review the full details of the Supply Agreement for a comprehensive understanding.

For further insights into CPMD stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskCannaPharmaRx Achieves First Harvest Milestone
TipRanks Canadian Auto-Generated NewsdeskCannaPharmaRx Targets High Growth in 2023
TipRanks Canadian Auto-Generated NewsdeskCannaPharmaRx Expands to Latin America with ICAN
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!